Home Uncategorized Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650...

Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650 million

157
0
SHARE

The Israeli company’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis Philip Morris, the international tobacco giant, is acquiring the Israeli company Syqe Medical in…

The post Philip Morris acquiring Cannabis inhaler developer Syqe Medical for up to $650 million appeared first on Cannabis Business Executive – Cannabis and Marijuana industry news.

See also  New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

LEAVE A REPLY

Please enter your comment!
Please enter your name here